Aagami Inc.is a life sciences consulting firm based in the suburbs of Chicago, offering Strategic Consulting and Technology Licensing Services for Life Science (biotech, pharmaceutical and medical devices) companies, focused on India and Emerging Markets.

Aagami Partners bring several decades of operational experience globally, connections at C-Level people with Indian Life-sciences companies and most importantly deep knowledge of India-business-practices.

The company has supported small and large life science companies from all over the world, mainly in the United States, Europe, India, Australia, and Japan in their quest for Indian market and or resources. 

These services include finding right service providers, right alliance partners, JV partners, M&A Targets, Contract Sales/Marketing company, In-Licensing or Out-Licensing deals etc., in the business of Life Sciences including Investing either way. 

Strategic Consulting Services

Strategic Consulting Services: Since its inception in February 2003, Aagami has supported small and large life science companies from all over the world, mainly in the United States, Europe, India, Japan, and Australia. These services include finding right service providers, right alliance partners, JV partners, M&A Targets, Contract Sales/Marketing company, In-Licensing or Out-Licensing deals etc., in short everything in the business of Life Sciences including Investing either way.

Technology Licensing Services

The TLO (Technology Licensing Organization) services of Aagami offer US Universities and companies Out-Licensing services to companies mainly in India.

Market Intelligence

Report Available - A must read for global companies who wish to collaborate with Indian companies

This research report reveals how and what Indian companies are doing in the area of drug research, and details out which companies are most active in the area

 The report consists of 45 pages. Below is a top level view of the contents:

• Overview: Historical perspective of Indian Pharma market
• Current status
  • Top 10 Indian Pharma companies by Sales and their R&D Expenses
  • Deals : Partnering of MNCs with Indian companies- Collaborative research, R&D service agreement
  • Paradigm Shift- "Hybrid Model"
  • India as a destination for conducting clinical research outsourcing and conducting global trials
  • MNC CRO in India
  • Indian companies' move up the value curves
• Trends in Drug Research
  • Top 5 Therapy areas for Drug Research
  • Key therapy area for NCE of 10 Indian companies
  • Therapeutic segment sales as of March 2011
• India's IP regime & Government Initiatives
• Benefits of Collaborations
• Conclusion

Value Pricing

• Summary PDF free

• $99.00 for Full Report in PDF format

Interested and need to know more about placing an order?

Please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.  or call +1-630-799-1572